Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290810
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2006-02-09
Brief Title:
Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Chronic Lymphocytic Leukemia |
| B-cell Chronic Lymphocytic Leukemia |
Keywords: